Substance / Medication

Prednisone

Overview

Active Ingredient
prednisone
RxNorm CUI
8640

Indications

Prednisone tablets USP are indicated in the following conditions: Endocrine Disorders Primary or secondary adrenocortical insufficiency (hydrocortisone or cortisone is the first choice: synthetic analogs may be used in conjunction with mineralocorticoids where applicable; in infancy mineralocorticoid supplementation is of particular importance); congenital adrenal hyperplasia; hypercalcemia associated with cancer; nonsuppurative thyroiditis. Rheumatic Disorders As adjunctive therapy for short-te

Labeler: REMEDYREPACK INC.Updated: 2026-02-18T00:00:00.000ZFull label on DailyMed

Contraindications

When this intervention should not be used

Prednisone tablets are contraindicated in systemic fungal infections and known hypersensitivity to components.

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Detailed dosage and administration information is available in the full FDA drug label.

View full prescribing information on DailyMed

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

Clinical Trials

107 trials linked to this intervention

107
Total Trials
36
Recruiting
20
With Results

Research Evidence

Published studies and systematic reviews

Sort:
Treatment with low-dose prednisone in refractory obstetric antiphospholipid syndrome: A retrospective cohort study and meta-analysis.
Riancho-Zarrabeitia Leyre, Lopez-Marin Laura, Cacho Pedro Muñoz et al. · Lupus · 2022
PMID: 35410552Meta-Analysis
Dexamethasone Versus Prednisone or Prednisolone for Acute Pediatric Asthma Exacerbations in the Emergency Department: A Meta-Analysis.
Cai Kai-Jin, Su Shi-Qing, Wang Yao-Guo et al. · Pediatr Emerg Care · 2021
PMID: 32149991Meta-Analysis
Meta-analyses of deflazacort versus prednisone/prednisolone in patients with nonsense mutation Duchenne muscular dystrophy.
Shieh Perry B, Elfring Gary, Trifillis Panayiota et al. · J Comp Eff Res · 2021
PMID: 34693725Meta-Analysis
Prednisone and azathioprine in patients with inflammatory cardiomyopathy: systematic review and meta-analysis.
Timmermans Philippe, Barradas-Pires Ana, Ali Omar et al. · ESC Heart Fail · 2020
PMID: 33121219Meta-AnalysisFull text (PMC)

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Adverse reaction and safety data for this drug is sourced from the FDA-approved label.

View adverse reactions & drug interactions on DailyMed

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Health Goals

Goals connected through associated conditions

Quick Facts

Type
Substance / Medication
Fully Specified Name
Prednisone (substance)
SNOMED CT
116602009
UMLS CUI
C0032952
RxNorm CUI
8640
Labeler
REMEDYREPACK INC.

Clinical Data

This intervention maps to 34 entities in the Ltrl knowledge graph.

20
Conditions
7
Biomarkers
5
Specialists
0
Symptoms
107
Clinical Trials

Data is sourced from SNOMED CT, UMLS, and the Ltrl clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.